Biomerica (NASDAQ:BMRA) Stock Price Crosses Below Two Hundred Day Moving Average – What’s Next?

Biomerica, Inc. (NASDAQ:BMRA)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $3.63 and traded as low as $2.82. Biomerica shares last traded at $2.88, with a volume of 47,936 shares trading hands.

Biomerica Stock Performance

The firm’s 50 day moving average price is $3.19 and its two-hundred day moving average price is $3.63. The company has a market cap of $8.12 million, a P/E ratio of -1.24 and a beta of 0.35.

Institutional Trading of Biomerica

An institutional investor recently bought a new position in Biomerica stock. Bulltick Wealth Management LLC purchased a new stake in shares of Biomerica, Inc. (NASDAQ:BMRA) in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 137,149 shares of the company’s stock, valued at approximately $78,000. Bulltick Wealth Management LLC owned approximately 5.39% of Biomerica at the end of the most recent quarter. 22.28% of the stock is owned by institutional investors.

Biomerica Company Profile

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.